understanding the parkinson's disease

23
Parkinson’s disease by Syed Baseeruddin Alvi (09)

Upload: syed-nayyer-alvi

Post on 07-May-2015

4.139 views

Category:

Science


0 download

DESCRIPTION

parkinson's disease pathophysiology, treatment...

TRANSCRIPT

Page 1: Understanding the Parkinson's disease

Parkinson’s disease

by Syed Baseeruddin Alvi (09)

Page 2: Understanding the Parkinson's disease

INTRODUCTION• Parkinsonism is a clinical syndrome comprising

combinations of motor problems—namely, bradykinesia,

resting tremor, rigidity, flexed posture, “freezing,” and loss

of postural reflexes.

• Studied and discovered by James

Parkinson (1817) which he called the shaking palsy

and by the Latin term paralysis agitans.

• Pathology shows loss of neuromelanin-containing

monoamine neurons, particularly dopamine (DA) neurons

in the substantia nigra pars compacta.

Page 3: Understanding the Parkinson's disease

• Examinations reveals the presence of cytoplasmic

eosinophilic inclusions Lewy bodies in monoamine

neurons.

• The loss of DA content in the nigrostriatal neurons

accounts for many of the motor symptoms which is due

to neuronal degradation

• Six cardinal clinical features of parkinsonism:Tremor at rest Bradykinesia Loss of postural

reflexes

Rigidity Flexed posture of neck, trunk, and limbs

Freezing phenomenon

Page 4: Understanding the Parkinson's disease

Concept on pathogenesis of Parkinson’s disease.

Page 5: Understanding the Parkinson's disease

The five stages of parkinson’s disease:

Stage 1:Unilateral involvement only with minimal or no functional impairment

Stage 2:Bilateral or midline involvement, without balance impairment

Stage 3:Impairment of righting reflex

Stage 4:Fully developed and severely disabling

Stage 5:Confinement to bed or wheel chair.

Page 6: Understanding the Parkinson's disease

Pathogenesis of PD:

Page 7: Understanding the Parkinson's disease

Pathogenesis of PD:

Page 8: Understanding the Parkinson's disease

Pathogenesis of PD:

Page 9: Understanding the Parkinson's disease

Drugs used in treatment of PD:

Page 10: Understanding the Parkinson's disease
Page 11: Understanding the Parkinson's disease

Dopamine precursor:

Levodopa (L-DOPA, LARODOPA, L-3,4

dihydroxyphenylalanine), the metabolic precursor of

dopamine, is the single most effective agent in the

treatment of PD .

It is inert both therapeutic & adverse effects are due

to decarboxylation , central and peripheral respectively .

In practice it is always administered in combination

with peripherally acting inhibitor of aromatic L-amino acid

decarboxylase ( carbidopa , benserazide)

Page 12: Understanding the Parkinson's disease

Site of action:

Page 13: Understanding the Parkinson's disease

Adverse reactions:

Involuntary muscular twitching of the limbs or facial

muscles

muscular spasms most often affecting the tongue, jaw,

eyes, and neck

mental changes, such as depression, psychotic

episodes, paranoia, and suicidal tendencies.

less serious adverse reactions include anorexia,

nausea, vomiting, abdominal pain, dry mouth, difficulty

in swallowing, increased hand tremor, headache, and

dizziness.

Page 14: Understanding the Parkinson's disease

Anticholinergic drugs:

Drugs with anticholinergic activity inhibit acetylcholine

(a neurohormone produced in excess in Parkinson’s disease)

in the CNS. Drugs with anticholinergic activity are generally

less effective than levodopa.

Page 15: Understanding the Parkinson's disease

Adverse reactions:

Dry mouth, blurred vision, dizziness, mild nausea, and

nervousness.

Other adverse reactions may include skin rash, urticaria

urinary retention, tachycardia, muscle weakness,

disorientation, and confusion.

COMT inhibitors:

These drugs prolong the effect of levodopa by blocking

(COMT). When given with levodopa, the COMT inhibitors

increase the plasma concentrations and duration of action

of levodopa.

Page 16: Understanding the Parkinson's disease

Adverse reactions:

Disorientation, confusion, light-headedness, dizziness,

dyskinesias, hyperkinesias, nausea, vomiting, hallucinations,

and fever

Other adverse reactions are orthostatic hypotension,

sleep disorders, excessive dreaming, and muscle cramps

Dopamine receptor agonists (non ergot):

It is thought that these drugs act directly on

postsynaptic dopamine receptors of nerve cells in the

brain, mimicking the effects of dopamine in the brain.

Page 17: Understanding the Parkinson's disease

Adverse reactions:

Nausea, dizziness, postural hypotension, hallucinations,

somnolence, vomiting, confusion, visual disturbances,

abnormal involuntary movements, and headache.

Selective MAO-B Inhibitors:

By interfering with one of the enzymes that break

down dopamine (monoamine oxidase, or MAO-B),

they can enhance and prolong the effect of each

dopamine molecule.

Page 18: Understanding the Parkinson's disease
Page 19: Understanding the Parkinson's disease

Treatment:

Page 20: Understanding the Parkinson's disease
Page 21: Understanding the Parkinson's disease
Page 22: Understanding the Parkinson's disease

Surgical Therapy:

Page 23: Understanding the Parkinson's disease